Qube Research & Technologies LTD Novo Nordisk A S Transaction History

Qube Research & Technologies LTD

$82.3 Billion
Q1 2025

A detailed history of Qube Research & Technologies LTD transactions in Novo Nordisk A S stock. As of the latest transaction made, Qube Research & Technologies LTD holds 883,125 shares of NVO stock, worth $44.2 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

883,125

Previous 855,142 3.27%

Holding current value

$44.2 Million

Previous $73.6 Million 16.63%

% of portfolio

0.07%

Previous 0.1%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$69.3 - $90.95 $1.94 Million - $2.55 Million	27,983 Added 3.27%	883,125 $61.3 Million
Q4 2024 Feb 14, 2025	BUY	$85.0 - $120.04 $16.4 Million - $23.2 Million	192,899 Added 29.13%	855,142 $73.6 Million
Q3 2024 Nov 14, 2024	SELL	$119.07 - $145.42 $7.67 Million - $9.36 Million	-64,399 Reduced 8.86%	662,243 $78.9 Million
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $798,964 - $956,531	6,511 Added 0.9%	726,642 $104 Million
Q1 2024 May 14, 2024	BUY	$102.11 - $135.92 $37 Million - $49.3 Million	362,361 Added 101.28%	720,131 $92.5 Million
Q4 2023 Feb 13, 2024	SELL	$87.78 - $105.45 $20.8 Million - $24.9 Million	-236,554 Reduced 39.8%	357,770 $37 Million
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $40.1 Million - $88.1 Million	441,288 Added 288.36%	594,324 $54 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $23.9 Million - $26.4 Million	153,036 New	153,036 $24.8 Million
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $5.52 Million - $6.77 Million	-57,898 Reduced 53.73%	49,858 $4.97 Million
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $11.1 Million - $13.1 Million	107,756 New	107,756 $12 Million
Q1 2022 May 09, 2022	SELL	$93.1 - $112.54 $237,777 - $287,427	-2,554 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$95.88 - $117.08 $5.65 Million - $6.9 Million	-58,921 Reduced 95.85%	2,554 $286,000
Q3 2021 Nov 12, 2021	BUY	$84.42 - $106.62 $5.19 Million - $6.55 Million	61,475 New	61,475 $5.9 Million
Q2 2021 Aug 13, 2021	SELL	$67.66 - $84.76 $2.46 Million - $3.08 Million	-36,359 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$67.06 - $75.82 $913,893 - $1.03 Million	-13,628 Reduced 27.26%	36,359 $2.45 Million
Q4 2020 Feb 16, 2021	SELL	$63.89 - $73.8 $942,696 - $1.09 Million	-14,755 Reduced 22.79%	49,987 $3.49 Million
Q3 2020 Nov 12, 2020	SELL	$63.69 - $70.22 $1.48 Million - $1.63 Million	-23,180 Reduced 26.36%	64,742 $4.5 Million
Q2 2020 Aug 14, 2020	BUY	$58.54 - $67.94 $5.15 Million - $5.97 Million	87,922 New	87,922 $5.76 Million
Q1 2020 May 15, 2020	SELL	$49.46 - $64.78 $611,177 - $800,486	-12,357 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$49.86 - $58.26 $193,706 - $226,340	-3,885 Reduced 23.92%	12,357 $715,000
Q3 2019 Nov 13, 2019	BUY	$47.54 - $53.43 $772,144 - $867,810	16,242 New	16,242 $840,000
Q2 2018 Aug 14, 2018	SELL	$44.29 - $50.42 $2,170 - $2,470	-49 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$48.49 - $58.14 $2,376 - $2,848	49 New	49 $2,000

Others Institutions Holding NVO

# of Institutions

1,760

Shares Held

338M

Call Options Held

11M

Put Options Held

15.9M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $113B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Novo Nordisk A S Transaction History